Afam A Okoye - OHSU
Afam is currently a Professor at VGTI and a core scientist within the Division of Pathobiology and Immunology, at the Oregon National Primate Center. He is also an Affiliate Faculty in the Department of Molecular Microbiology & Immunology, OHSU School of Medicine.
Afam Okoye, Ph.D. - OHSU
Okoye’s lab is evaluating the potential of a number of vaccine-platforms to enhance cellular immunity in the setting of a previously established, cART-suppressed infection, with the goal of establishing long-term control of HIV replication after cART cessation.
Meet Our Team - OHSU
Afam Okoye Associate Professor Afam obtained his B.Sc. in Microbiology from the University of Nigeria and M.Sc. in Biotechnology from the Nottingham Trent University.
Afam Okoye - Professor - Oregon Health & Science University
2015年1月19日 · Professor at Oregon Health & Science University. My research is focused on understanding the mechanisms that maintain HIV latency in people living with HIV infection and developing therapeutic...
- 职位: Professor at Oregon Health & …
- 位置: Oregon Health & Science University
- 500+ 连接数
Afam Okoye - dare
Associate Professor Okoye's research focuses on utilizing nonhuman primate models to understand the barriers to HIV eradication during antiretroviral therapy (ART) and to develop therapeutic approaches aimed at achieving durable remission from …
Afam Okoye | IAS 2023 | International AIDS Society (IAS)
Afam Okoye is an Associate Professor at the Vaccine & Gene Therapy Institute (VGTI), the Division of Pathobiology and Immunology, Oregon National Primate Research Center and Department of Molecular Microbiology and Immunology, School of Medicine, Oregon Health & Science University (OHSU).
Afamefuna Okoye - Oregon Health & Science University
Dive into the research topics where Afamefuna Okoye is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Afam Okoye's research works | Vaccine & Gene Therapy Institute …
Afam Okoye's 40 research works with 1,701 citations and 3,520 reads, including: OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab
Afam Okoye (0000-0001-9671-550X) - ORCID
2024年4月9日 · Afam Okoye Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy. The Journal of clinical investigation
Afam A. Okoye, PhD - IAS-USA
Afam A. Okoye, PhD Associate Professor Oregon Health and Science University Beaverton, OR